Research Summary
Whole exome sequencing (WES) is a cutting-edge genomic technique used to analyze the protein-coding regions of an individual's genome, known as the exome. The exome represents only about 1-2XX% of the entire genome but contains the majority of disease-causing mutations. WES involves capturing and sequencing the DNA fragments corresponding to these exons using high-throughput sequencing technologies. By sequencing the exome, researchers and clinicians can identify genetic variations, mutations, and alterations that may be associated with various diseases, disorders, or conditions. WES is particularly useful for identifying rare genetic diseases, elucidating the genetic basis of inherited disorders, and guiding personalized medicine approaches, such as targeted therapies or precision medicine. It offers a comprehensive and cost-effective approach to genomic analysis, providing valuable insights into the genetic underpinnings of human health and disease.
According to DIResearch's in-depth investigation and research, the global Whole Exome Sequencing market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen, BGI, Novo Gene etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Whole Exome Sequencing. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Whole Exome Sequencing market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Whole Exome Sequencing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Whole Exome Sequencing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Whole Exome Sequencing Include:
Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing Product Segment Include:
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing Product Application Include:
Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Whole Exome Sequencing Industry PESTEL Analysis
Chapter 3: Global Whole Exome Sequencing Industry Porter's Five Forces Analysis
Chapter 4: Global Whole Exome Sequencing Major Regional Market Size and Forecast Analysis
Chapter 5: Global Whole Exome Sequencing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Whole Exome Sequencing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Whole Exome Sequencing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Whole Exome Sequencing Market Overview 1.1 Product Definition and Statistical Scope 1.2 Whole Exome Sequencing Product by Type 1.2.1 Global Whole Exome Sequencing Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Agilent HaloPlex 1.2.3 Agilent SureSelect 1.2.4 Agilent SureSelect QXT 1.2.5 Illumina TruSeq Exome 1.2.6 Roche Nimblegen SeqCap 1.2.7 MYcroarray MYbaits 1.3 Whole Exome Sequencing Product by Application 1.3.1 Global Whole Exome Sequencing Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Correlation Research of Normal Human 1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery 1.3.4 The Research of Complex Diseases 1.3.5 Mouse Exome Sequencing 1.4 Global Whole Exome Sequencing Market Revenue Analysis (2019-2030) 1.5 Whole Exome Sequencing Market Development Status and Trends 1.5.1 Whole Exome Sequencing Industry Development Status Analysis 1.5.2 Whole Exome Sequencing Industry Development Trends Analysis 2 Whole Exome Sequencing Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Whole Exome Sequencing Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Whole Exome Sequencing Market Analysis by Regions 4.1 Whole Exome Sequencing Overall Market: 2023 VS 2024 VS 2030 4.2 Global Whole Exome Sequencing Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Whole Exome Sequencing Revenue and Market Share by Region (2019-2024) 4.2.2 Global Whole Exome Sequencing Revenue Forecast by Region (2025-2030) 5 Global Whole Exome Sequencing Market Size by Type and Application 5.1 Global Whole Exome Sequencing Market Size by Type 5.2 Global Whole Exome Sequencing Market Size by Application 6 North America 6.1 North America Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Whole Exome Sequencing Market Size by Type 6.4 North America Whole Exome Sequencing Market Size by Application 6.5 North America Whole Exome Sequencing Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Whole Exome Sequencing Market Size by Type 7.4 Europe Whole Exome Sequencing Market Size by Application 7.5 Europe Whole Exome Sequencing Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Whole Exome Sequencing Market Size by Type 8.4 China Whole Exome Sequencing Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Whole Exome Sequencing Market Size by Type 9.4 APAC (excl. China) Whole Exome Sequencing Market Size by Application 9.5 APAC (excl. China) Whole Exome Sequencing Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Whole Exome Sequencing Market Size by Type 10.4 Latin America Whole Exome Sequencing Market Size by Application 10.5 Latin America Whole Exome Sequencing Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Whole Exome Sequencing Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Whole Exome Sequencing Market Size by Type 11.4 Middle East & Africa Whole Exome Sequencing Market Size by Application 11.5 Middle East & Africa Whole Exome Sequencing Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Whole Exome Sequencing Market Revenue by Key Manufacturers (2020-2024) 12.2 Whole Exome Sequencing Competitive Landscape Analysis and Market Dynamic 12.2.1 Whole Exome Sequencing Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Illumina 13.1.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Illumina Whole Exome Sequencing Product Portfolio 13.1.3 Illumina Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Thermo Fisher 13.2.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Thermo Fisher Whole Exome Sequencing Product Portfolio 13.2.3 Thermo Fisher Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Roche 13.3.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Roche Whole Exome Sequencing Product Portfolio 13.3.3 Roche Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Angilent 13.4.1 Angilent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Angilent Whole Exome Sequencing Product Portfolio 13.4.3 Angilent Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Eurofins 13.5.1 Eurofins Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Eurofins Whole Exome Sequencing Product Portfolio 13.5.3 Eurofins Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Sengenics 13.6.1 Sengenics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Sengenics Whole Exome Sequencing Product Portfolio 13.6.3 Sengenics Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Ambry 13.7.1 Ambry Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Ambry Whole Exome Sequencing Product Portfolio 13.7.3 Ambry Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Macrogen 13.8.1 Macrogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Macrogen Whole Exome Sequencing Product Portfolio 13.8.3 Macrogen Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 BGI 13.9.1 BGI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 BGI Whole Exome Sequencing Product Portfolio 13.9.3 BGI Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Novo Gene 13.10.1 Novo Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Novo Gene Whole Exome Sequencing Product Portfolio 13.10.3 Novo Gene Whole Exome Sequencing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Whole Exome Sequencing Industry Chain Analysis 14.2 Whole Exome Sequencing Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Whole Exome Sequencing Typical Downstream Customers 14.4 Whole Exome Sequencing Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support